DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 1Olpha
03 1Abacus Medicine
04 44AstraZeneca
05 1Cipla
06 2Olon S.p.A
07 2Pinnacle Life Science
08 1Sandoz B2B
09 2TherDose Pharma
10 1Zydus Pharmaceuticals
01 1CAPSULE;ORAL
02 1Capsule
03 13Film Coated Tablet
04 2Film-Coated Tablet
05 1Hard Capsule
06 1Olaparib 50Mg 448 Unita' Oral Use
07 2Oral Solid Dosage Form
08 2TAB
09 5TABLET
10 2TABLET;ORAL
11 3Tablet
12 2Tablets
13 22Blank
01 2Allowed
02 2Approved
03 2Authorized
04 1Available Dossier- US-EU-RoW
05 1Cancelled
06 1DISCN
07 1Deregistered
08 1Dossier Readiness:Q3 2026
09 2Lead Market Dossiers- Under Development
10 2Marketed
11 1Not Marketed
12 2Originator
13 4Prescription
14 2RX
15 33Blank
01 5LYNPARZA
02 36Lynparza
03 1Lynparza 100
04 1Lynparza 100 mg
05 1Lynparza 150
06 1Lynparza 150 mg
07 3OLAPARIB
08 2Olaparib
09 7Blank
01 22Australia
02 2Canada
03 2Estonia
04 6India
05 3Italy
06 1Latvia
07 2Moldova
08 3Norway
09 2South Africa
10 3Spain
11 3Sweden
12 2Switzerland
13 6USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness:Q3 2026
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness:Q3 2026
Registration Country : Latvia
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LYNPARZA
Dosage Form : CAPSULE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2014-12-19
Application Number : 206162
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LYNPARZA
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2017-08-17
Application Number : 208558
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LYNPARZA
Dosage Form : TABLET;ORAL
Dosage Strength : 150MG
Packaging :
Approval Date : 2017-08-17
Application Number : 208558
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Lynparza
Dosage Form : Olaparib 50Mg 448 Unita' Oral Use
Dosage Strength : 448 cps 50 mg vial
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lynparza
Dosage Form : Film Coated Tablet
Dosage Strength : 100mg
Packaging :
Approval Date : 08/05/2018
Application Number : 20170407000065
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lynparza
Dosage Form : Film Coated Tablet
Dosage Strength : 150mg
Packaging :
Approval Date : 08/05/2018
Application Number : 20170407000072
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Lynparza
Dosage Form : Capsule
Dosage Strength : 50mg
Packaging :
Approval Date : 16/12/2014
Application Number : 20131002000126
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Lynparza
Dosage Form : Film Coated Tablet
Dosage Strength : 100mg
Packaging :
Approval Date : 27/09/2018
Application Number : 66745
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info :
Registration Country : USA
Brand Name : OLAPARIB
Dosage Form : TABLET
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number : 219410
Regulatory Info :
Registration Country : USA
Regulatory Info : Available Dossier- US-EU-RoW
Registration Country : Italy
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Available Dossier- US-EU-RoW
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : India
Brand Name : Olaparib
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Olaparib
Dosage Form : Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : USA
Brand Name : OLAPARIB
Dosage Form : TABLET
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number : 217936
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablets
Dosage Strength : 100mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablets
Dosage Strength : 150mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : USA
Brand Name : OLAPARIB
Dosage Form : TABLET
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number : 219893
Regulatory Info :
Registration Country : USA
